HRP20040582B1 - Amlopidine bezylate tablets with improved stability - Google Patents

Amlopidine bezylate tablets with improved stability

Info

Publication number
HRP20040582B1
HRP20040582B1 HR20040582A HRP20040582A HRP20040582B1 HR P20040582 B1 HRP20040582 B1 HR P20040582B1 HR 20040582 A HR20040582 A HR 20040582A HR P20040582 A HRP20040582 A HR P20040582A HR P20040582 B1 HRP20040582 B1 HR P20040582B1
Authority
HR
Croatia
Prior art keywords
improved stability
amlopidine
tablets
bezylate
lubricant
Prior art date
Application number
HR20040582A
Other languages
English (en)
Croatian (hr)
Inventor
Fekete P�l
Kir�lyn� Ign�cz M�ria
T�mpe P�ter
G�ra L�szl�n�
Szentgr�ti P�ln�
Leventiszn� Husz�r Magdolna
Thur�czi P�ln�
Lonkain� Magyar Olga
Original Assignee
Egis Gy�Gyszergy�R Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gy�Gyszergy�R Rt. filed Critical Egis Gy�Gyszergy�R Rt.
Publication of HRP20040582A2 publication Critical patent/HRP20040582A2/hr
Publication of HRP20040582B1 publication Critical patent/HRP20040582B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20040582A 2001-12-17 2004-06-23 Amlopidine bezylate tablets with improved stability HRP20040582B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0105345A HU226642B1 (en) 2001-12-17 2001-12-17 Amlodipine bezylate tablets having extended stability and process for producing the same
PCT/HU2002/000145 WO2003051364A1 (en) 2001-12-17 2002-12-17 Amlopidine bezylate tablets with improved stability

Publications (2)

Publication Number Publication Date
HRP20040582A2 HRP20040582A2 (en) 2005-02-28
HRP20040582B1 true HRP20040582B1 (en) 2007-08-31

Family

ID=90000366

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040582A HRP20040582B1 (en) 2001-12-17 2004-06-23 Amlopidine bezylate tablets with improved stability

Country Status (17)

Country Link
EP (1) EP1458384B1 (es)
AT (1) ATE333877T1 (es)
AU (1) AU2002353242A1 (es)
BG (1) BG108807A (es)
CZ (1) CZ2004791A3 (es)
DE (1) DE60213464T2 (es)
EA (1) EA006826B1 (es)
ES (1) ES2269787T3 (es)
HR (1) HRP20040582B1 (es)
HU (1) HU226642B1 (es)
LT (1) LT5241B (es)
LV (1) LV13243B (es)
PL (1) PL370420A1 (es)
RS (1) RS54304A (es)
SK (1) SK2862004A3 (es)
UA (1) UA74968C2 (es)
WO (1) WO2003051364A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006059217A1 (en) * 2004-12-01 2006-06-08 Ranbaxy Laboratories Limited Stable solid dosage forms of amlodipine besylate and processes for their preparation
JO3239B1 (ar) 2008-09-22 2018-03-08 Novartis Ag تركيبات جالينية من مركبات عضوية
JP4954961B2 (ja) * 2008-10-06 2012-06-20 大日本住友製薬株式会社 光安定性の向上した組成物
JP5689052B2 (ja) * 2011-12-26 2015-03-25 大日本住友製薬株式会社 光安定性の向上した組成物
EP2814465B1 (en) 2012-02-17 2019-07-03 Egis Gyógyszergyár Zrt. Pharmaceutical formulation having improved stability
PL236001B1 (pl) 2012-12-21 2020-11-30 Adamed Spolka Z Ograniczona Odpowiedzialnoscia Złożona kompozycja farmaceutyczna zawierająca kandesartan cyleksetylu oraz amlodypinę, sposób jej wytwarzania oraz jednostkowa postać dawkowania zawierająca tę kompozycję
US10350171B2 (en) 2017-07-06 2019-07-16 Dexcel Ltd. Celecoxib and amlodipine formulation and method of making the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
DE19857716A1 (de) * 1998-12-15 2000-06-21 Bayer Ag Neue feste Formulierung von Metrifonat
WO2003032954A1 (en) * 2001-10-17 2003-04-24 Dr. Reddy's Laboratories Ltd. Stabilized pharmaceutical formulations containing amlodipine maleate

Also Published As

Publication number Publication date
SK2862004A3 (en) 2004-11-03
RS54304A (en) 2006-12-15
EP1458384A1 (en) 2004-09-22
HRP20040582A2 (en) 2005-02-28
BG108807A (en) 2005-03-31
WO2003051364A1 (en) 2003-06-26
ES2269787T3 (es) 2007-04-01
LV13243B (en) 2005-05-20
EA200400801A1 (ru) 2004-12-30
LT5241B (lt) 2005-07-25
EA006826B1 (ru) 2006-04-28
HUP0105345A3 (en) 2007-08-28
LT2004062A (en) 2005-02-25
CZ2004791A3 (cs) 2004-10-13
DE60213464D1 (de) 2006-09-07
EP1458384B1 (en) 2006-07-26
HUP0105345D0 (en) 2002-02-28
AU2002353242A1 (en) 2003-06-30
HUP0105345A2 (hu) 2003-12-29
HU226642B1 (en) 2009-05-28
DE60213464T2 (de) 2007-03-01
PL370420A1 (en) 2005-05-30
ATE333877T1 (de) 2006-08-15
UA74968C2 (en) 2006-02-15

Similar Documents

Publication Publication Date Title
EE05383B1 (et) Polarlkarboksamiidhendid,ÁnendeÁvalmistamineÁjaÁkasutamineÁlipiiditasetÁalandavateÁtoimeainetenaÁningÁneidÁsisaldavÁfarmatseutilineÁkompositsioon
DE60121857D1 (de) Arzneimittelzusammensetzung mit verzögerter Wirkstoffabgabe
ATE250924T1 (de) Cyklosporin, hyaluronsäure und polysorbate enthaltenes augenarzneimittel
NO20043702L (no) 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
NO20054244D0 (no) Nitrogeninneholdende heterocykliske derivater og legemidler inneholdende de samme som den aktive bestanddel
DK1401501T3 (da) Orale farmaceutiske sammensætninger med modificeret frigivelse af den aktive ingrediens
DK1498411T3 (da) Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel
DK1499607T3 (da) 4-(piperidyl- og pyrrolidyl-alkyl-ureido)-quinoliner som urotensin II-receptorantagonister
HUP0204458A3 (en) Derivatives of quinoline as alpha-2 antagonists and pharmaceutical compositions containing them
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
DK1161228T3 (da) Præparat omfattende isoquercetin og ascorbinsyre i en sustained release-form
ES2130081B1 (es) Comprimido de maleato de trimebutina con recubrimiento laminar.
HRP20040582B1 (en) Amlopidine bezylate tablets with improved stability
ITMI20001093A0 (it) Composizioni a rilascio controllato contenenti un principio attivo, preferibilmente melatonina, e processo di preparazione delle stesse.
ZA948162B (en) Dihaiopropene compound, insecticide/acaricide, containing said dihalopropene compound as active ingredient, and intermediate compound for use in production of said dihalopropene compound.
AU2001277738A1 (en) Piperidine derivatives and drugs containing these derivatives as the active ingredient
TR200301931T2 (tr) Saç gelişiminde 3 konumundaki siklosporin türevlerinin kullanılması
DK1147105T3 (da) Optisk aktivt pyridyl-4H-1,2,4-oxadiazinderivat og anvendelse af dette til behandling af karsygdomme
HRP20010764B1 (en) Prucalopride oral solution
SE0001916D0 (sv) Novel formulation
TW200503709A (en) Itching treating agent containing piperidine derivative as active ingredient
DE60302951D1 (de) Pyroglutaminsäure-salz von Amlodipin
EP1059304A4 (en) NOVEL POLYSACCHARIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITIONS CONTAINING THESE NEW DERIVATIVES AS ACTIVE INGREDIENT
CA2340427A1 (en) Non-sedating diphenhydramine metabolites
IT1317288B1 (it) Struttura di tavola, particolarmente per ponteggi, scaffalature,soppalchi e simili.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20061108

Year of fee payment: 5

B1PR Patent granted
PBON Lapse due to non-payment of renewal fee

Effective date: 20071218